Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
32 participants
OBSERVATIONAL
2016-07-31
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
All patients undergoing medial quadrantectomy and simple mastectomy in 6 months period will be observed.
All patients receive: US guide parasternal block at T4 and T6 space with 6ml of ropivacaine 0,75% and PECS type 2 block performed with 24ml of ropivacaine 0,75%.
During surgery patients receive light sedation with continuous infusion of propofol
Will be observed:
Additional local anesthetic infiltration from surgeon. Pain at rest and during movement quantified as Numerical Rating Scores (0-10) during the first 12 hours postoperatively.
Eventual side effects such as nausea/vomiting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anesthetic Efficacy of PECS II Block and Parasternal Block
NCT03016117
PECS Block in Breast Surgery: an Observational Multicenter Study
NCT02414256
The Combination of PECS II Block and Parasternal Block for Radical Mastectomy
NCT03754816
Pecs II Block and PaB Could be an Alternative in Breast Surgery
NCT02865265
Analgesic Effect of Adding Thoracic Paravertebral Nerve Blocks to Modified PEC Block in Breast Cancer Surgery
NCT04056676
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA score I - II - III;
* undergoing elective medial quadrantectomy breast surgery;
* undergoing elective mastectomy not reconstruction breast surgery;
* signed informed consent;
Exclusion Criteria
* urgent/emergent surgery;
* postoperative transfer to the intensive care unit;
* known allergy to any drug medication;
* local skin infection;
* epilepsy;
* alcohol or drug abuse;
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituti Ospitalieri di Cremona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erika Basso Ricci
Anesthetist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ASST Cremona
Creom, Cremona, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANECR_01_17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.